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Despite recent international efforts to increase antiretroviral treatment (ART) coverage, 
more than 5 million people who need ART in developing countries do not receive such 
treatment. Shortages of human resources to treat HIV/AIDS (referred to herein as 
HRHA) are one of the main constraints to further scaling up ART. Planning expansion of 
ART depends on the ability to predict how many HRHA will be needed in the future. We 
investigate whether taking into account positive feedback from the current supply of 
HRHA to future HRHA need substantially alters predictions. This feedback occurs 
because an increase in the number of HRHA implies an increase in the number of 
individuals receiving ART and – because ART is a lifelong treatment and is effective in 
prolonging the lives of HIV-positive people – a rise over time in the number of people 
requiring ART. 
 
We formulate a discrete-time Markovian model to project HRHA need in three 
geographical regions in the developing world: sub-Saharan Africa (SSA), non-sub 
Saharan African low- and middle income countries (NSSA), and one specific country in 
SSA, South Africa (SA). To run the model, we use recently published estimates of ART 
coverage, HIV prevalence, HIV incidence, health worker emigration rates, mortality 
rates of people needing ART, and numbers of HRHA required to treat 1,000 ART 
patients. 
 
We find that feedback is a significant determinant of HRHA needed for universal ART 
coverage. Our model shows that with feedback SSA requires 1.4 times, NSSA requires 
0.8 times, and SA requires 3.3 times the size of their entire existing HRHA population to 
be added every year for the next 10 years to achieve universal ART coverage by 2017. 
Without feedback, the regions would require 0.6, 0.3 and 1.5 times the size of their 
respective HRHA populations to be added each year until 2017. Beyond 2017, 
sustaining universal coverage requires further HRHA increases until the system reaches 
steady state. 
 
‐ 2 ‐ We further find that ART coverage is sensitive to HRHA inflow and emigration, and that 
universal ART coverage is unlikely to be achieved and sustained with increased HRHA 
inflows alone, but will in many settings require decreased HRHA outflows, substantially 
reduced HIV incidence, or changes in the nature or organization of care.  
‐ 3 ‐ Introduction 
 
Despite recent international initiatives to scale up antiretroviral treatment (ART) (Clinton 
Foundation 2007; Global Fund to Fight AIDS, Tuberculosis and Malaria 2007; Médecins 
Sans Frontières 2007a; President’s Emergency Plan For AIDS Relief (PEPFAR) 2007),
 
more than 5 million people in developing countries who needed ART in December 2006 
did not receive it (World Health Organization (WHO) 2007), leading to large numbers of 
potentially avoidable deaths (Hogg et al. 1999; Bärnighausen 2007). In June 2006, the 
General Assembly of the United Nations committed itself to the goal of achieving 
universal access to HIV care by 2010 (United Nations 2007). In many developing 
countries, the binding constraint to increasing ART coverage is not drugs, laboratory 
equipment, or facilities, but human resources to treat HIV/AIDS (HRHA) (Clark 2006; 
Hosseinipour 2002; Institute of Medicine 2007; Kober, and Van Damme 2004; Marchal, 
De Brouwere, and Kegels 2005; Marchal, Kegels, and De Brouwere 2004; Médecins 
Sans Frontières 2007b; Ooms, Van Damme, and Temmerman 2007; Van Damme, 
Kober, and Laga 2006). Realistic estimates of the number of health workers required to 
achieve and maintain universal ART coverage in future years are necessary to devise 
appropriate strategies for health worker education, training, and retention 
(Bärnighausen 2007). 
 
Estimating the number of additional HRHA currently needed to achieve universal ART 
coverage in developing countries is relatively easy, using, for instance, recent empirical 
estimates of the number of health workers needed to provide ART to 1,000 patients in 
developing countries (Hirschhorn, Oguda, Fullem, Dreesch, and Wilson 2006) and 
estimates of current unmet need for ART (WHO 2007). Such static estimation of HRHA 
need is, however, only of limited value for a number of reasons. First, while most of the 
other inputs needed to provide ART, such as antiretroviral drugs and medicines to 
prevent and treat opportunistic infections, laboratory equipment to measure CD4 
counts, and health care facilities, can be relatively quickly scaled up if sufficient funds 
are available, HRHA cannot be increased quickly, because of long education and 
1 training times (Bossert, Bärnighausen, Bowser, Mitchell and Gedik 2007). Any 
estimation of HRHA need must thus span a period of many years.  
 
Second, the number of HRHA needed to achieve universal ART coverage in the future 
is not independent of the current HRHA numbers. The more HRHA are available, the 
larger the number of people who currently receive ART will be, and because ART is a 
lifelong treatment and is effective in prolonging the lives of HIV-positive people in 
developing countries (Braitstein et al. 2006; Merson, Dayton, and O'Reilly 2000; Herbst, 
Cooke, Bärnighausen, Kany Kany, Tanser, and Newell 2008), the larger the number of 
people who require ART in the future will become – that is, there is positive feedback 
from HRHA numbers to HRHA need.  
 
Third, HRHA themselves are at risk of contracting HIV and becoming patients in need of 
ART, especially in countries with generalized HIV epidemics (Connelly et al. 2007; 
Ncayiyana 2004). In many developing countries, large numbers of health workers in 
need of ART are not receiving it (Chen and Hanvoravongchai 2005; Shisana 2007; 
Tawfik and Kinoti 2003). We would expect that the probability of a health worker 
receiving ART increases with increasing numbers of HRHA. ART will increase the life 
expectancy of HIV-positive HRHA, and thus decrease the need for HRHA over time – 
that is, there is negative feedback from HRHA numbers to HRHA need. 
 
We project the ART coverage that can be achieved under varying assumptions about 
HRHA inflow from the health worker education system and outflow because of 
emigration or deaths. We also investigate the effects of changes in HRHA HIV 





Model: conceptual description 
Our model is a simple, discrete-time, Markovian deterministic system with two main 
population pools (Law and Kelton 2000): HRHA and people needing ART. In order to 
investigate whether changes in HRHA HIV incidence or HRHA ART coverage 
appreciably change the long-term need to add HRHA to the pool of existing health 
workers, we divide HRHA into four subpopulations: HIV-negative HRHA, HIV-positive 
HRHA who do not (yet) need ART, HIV-positive HRHA who need ART but are not 
receiving it, and HIV-positive HRHA needing and receiving ART. Time increments are 
yearly. 
 
We chose a deterministic rather than a stochastic system, because our model asks 
questions at the regional or the national level. At these levels, data characterizing the 
statistical properties of random quantities are not available; we thus judged that 
deterministic point estimates were better than introducing additional stochastic 
mathematical structure into the model without evidence to guide the selection of such a 
structure. We chose a Markovian system (that is, where the state of the system, people 
needing ART and HRHA, at time t + 1 depends only on the state of the system at time t 
and not on previous states), because a Markovian system is comparatively simple to 
implement and sufficient to investigate feedback structures, such as the feedback from 
health workers providing ART to ART need.  
 
Model: details 
The patient population needing ART, starting from a given initial size at time t = 0, 
evolves as follows. At the beginning of each period t, new infections occur at a given 
annual rate. The newly HIV-positive people then enter a fixed latency period of 10 years 
(compare Boerma et al. 2006) during which they are exposed to general population 
mortality, but do not yet need ART. The proportion of HIV-positive people who survive 
the latency period enters the population needing treatment at the beginning of each 
3 period. The previous period’s treated and untreated population sizes are then reduced 
using their respective annual mortality rates. 
 
Given the current number of HRHA, the number of patients treated is computed 
assuming a fixed HRHA-to-patient ratio of 1 team to 1,000 patients. A recent review of 
staffing patterns in ART programs in developing countries found that one to two doctors, 
up to three pharmacy staff, and two to seven nurses were needed to provide ART to 
1,000 patients (Hirschhorn et al. 2006). The ratio used in this model employs the lower 
bound of the number of doctors needed to provide ART to 1,000 patients: by scaling our 
estimates of HRHA need by a constant factor, we can easily translate them into the 
need for nurses or pharmacy staff. In our model, however, one HRHA represents a 
team of health workers sufficient to provide ART to 1,000 patients. The precise makeup 
of the team is irrelevant to our model. The only assumptions for our results to hold are 
that the provision of ART by health workers is as effective in reducing mortality as the 
provision of ART during the first phase of ART scale-up in low-income countries 
(Braitstein et al. 2006) and that health workers are internationally mobile. 
 
The evolution of HRHA in the model is similar, in principle, to the evolution of the 
population needing ART, but more detailed. The size of the HIV-negative HRHA pool 
decreases in each period because of mortality and emigration. The remaining number 
of HIV-negative HRHA is further diminished because of new HIV infections. At the same 
time, new HRHA are added to the subpopulation of HIV-negative HRHA at a given 
annual rate, yielding the HIV-negative HRHA population at the start of the next period. 
During the latency period from HIV infection to ART need, the size of the HIV-positive 
HRHA pool is decreased because of mortality and emigration. HRHA who neither die 
nor emigrate during the 10 years from infection to need for treatment are added to the 
subpopulation of HIV-positive HRHA needing ART. 
 
The HRHA who need treatment at the beginning of a period are split into two 
subpopulations: those who received treatment during the previous period and those 
who did not. Both subpopulations are reduced by their respective mortality and 
4 emigration rates. The number of HRHA needing treatment in the current period is 
computed as the sum of the HRHA needing treatment who have remained in the 
subpopulation from the previous period and the HIV-positive HRHA who have newly 
become in need of ART. 
 
 
Model: parameter estimates 
Table 1 presents estimates for model parameters for three regional base cases, as 
derived from published studies. We divided all developing countries into two separate 
base cases, sub-Saharan Africa (SSA) and non–sub Saharan African (NSSA), because 
the HIV epidemic (WHO 2007), health worker emigration (Docquier and Bhargava 
2007), and mortality (World Bank 2007) are very different in these two sets of countries. 
We added a third base case, the country of South Africa (SA). We included SA as a 
separate base in order to apply our model to a country with substantially higher HIV 
prevalence, HIV incidence, and HRHA emigration rates than both the SSA and the 
NSSA averages. 
 
Whenever rate estimates for parameters such as HIV incidence, mortality or emigration 
were available in the literature, we converted the rates into annual probabilities, 
because we model time as consisting of discrete one-year-long units. 
 
< Table 1 > 
 
The initial estimates of the number of people receiving ART and the number of people 
needing but not receiving ART in the three base cases are from a recent joint 
publication by WHO, the Joint United Nations Programme on HIV/AIDS (UNAIDS), and 
the United Nations Children’s Fund (UNICEF) (WHO, UNAIDS, and UNICEF 2007). 
Estimates of mortality among people receiving ART were based on a review of mortality 
in 18 ART programs in low-income countries (Braitstein et al. 2006). Estimates of 
mortality among people needing ART but not receiving it were taken from a study in 
South Africa (Badri, Lawn, and Wood 2006).  
5  
In developing countries in the early phases of the HIV epidemic, people with high 
educational attainment, such as health workers, were at higher risk of HIV infection than 
the general population (Hargreaves and Glynn 2002). However, recent studies of HIV 
infection among health workers have found HIV prevalence in health workers to be 
similar to the prevalence in the general population (Connelly et al. 2007; Shisana, Hall, 
Maluleke, Chauveau, and Schwabe 2004). Therefore for the initial split into HIV-
negative and HIV-positive HRHA subpopulations, we assumed that HIV prevalence and 
HIV incidence among health workers equaled the prevalence and incidence in the 
general adult population in the three regional base cases. We calculated the annual 
probability of HIV acquisition for SSA and NSSA countries using estimated numbers (by 
world region) of people who were newly infected with HIV during 2007 and estimated 
numbers of people who needed to be excluded from the population at risk of HIV 
incidence in 2007 because they had already contracted HIV (UNAIDS and WHO 2007). 
We derived our estimate of the annual probability of HIV acquisition for SA from the 
2005 South African National HIV Prevalence, HIV Incidence, Behaviour, and 
Communication Survey (Rehle, Shisana, Pillay, Zuma, Puren, and Parker 2007; 
Shisana et al. 2005).  
 
We assumed that initially 15% of HIV-positive HRHA were in need of ART. This number 
falls within the range of the proportion of HIV-positive people needing treatment found in 
studies across Africa (1% - 34%) (Williams, Korenromp, Gouws, Schmid, Auvert, and 
Dye 2006) when ART need is defined as a CD4 count of less than 200 cells per 
microliter (WHO 2004).  
 
We used a recently published dataset, Medical Brain Drain: Physicians Emigration 
Rates 1991-2004, to derive annual probabilities of HRHA emigration (Docquier and 
Bhargava 2007a). Docquier and Bhargava use annual reports on physician immigration 
by 16 countries belonging to the Organisation for Economic Co-operation and 
Development (OECD) and data on physician numbers from the World Development 
Indicators to derive annual estimates of doctors’ emigration rates for 192 countries 
6 (Docquier and Bhargava 2007b). We took estimates of the number of doctors from the 
same dataset (for each country-year) as the weighting factor to calculate a weighted 
average annual emigration probability for SSA and NSSA. We used the most recent 
estimate of the probability of annual doctor emigration available for the SA base case 
(i.e. for the year 2004) (Docquier and Bhargava 2007a).  
 
In addition to emigration, we assumed that health workers leave the HRHA pool 
because they retire or die. We derived a combined annual probability of either of the two 
events from an estimate of the work lifetime of HIV-negative HRHA. We calculated the 
work lifetime as the difference between the weighted average life expectancy across the 
countries included in each of the base case regions (where the weighting factors are the 
country population sizes from the World Development Indicators (World Bank 2007)) or 
a retirement age of 60, whichever is lower, and an assumed average health worker age 
of 30. Estimates of new health workers added annually to the HRHA pool were inferred 
by assuming the current HRHA populations in the three regions were in steady state 





If the HRHA inflow and emigration rates remain at base-case levels, in 10 years ART 
coverage will have dropped in all three regional base-case scenarios, most substantially 
in SA, less in SSA, and least in NSSA (Figure 1). Table 2 shows results for the three 
regional base-case scenarios and for univariate sensitivity analyses when individual 
model parameters are varied. Table 3 shows the number of HRHA that need to be 
added to the existing HRHA population each year to achieve universal ART coverage in 
10 years. 
 
< Figure 1, Table 2, Table 3 > 
 
7 Result 1: In all three base cases, the positive feedback from HRHA numbers to HRHA 
need (due to the effect of ART on mortality) is significant. At higher levels of ART 
coverage the feedback effect becomes larger; at near-universal coverage it is the main 
determinant of HRHA need. 
 
Under base-case assumptions, ART coverage is lower for the model with feedback than 
for the model without feedback (by 3-7 percentage points). For the model with feedback, 
outputs are listed in Tables 2 and 3. Without feedback, 22-35% ART coverage is 
obtained by year 10 (30% in SSA; 35% in NSSA; 22% in SA) as well as in steady state. 
With feedback, as shown in Table 2 and Figure 1, coverage in year 10 drops to 19-28% 
(25% in SSA; 28% in NSSA; 19% in SA) and remains approximately at that level in 
steady state. At or near universal coverage, the feedback effect is the main determinant 
of HRHA need. Without feedback, the HRHA inflow rate required to achieve universal 
coverage in year 10 is 788 HRHA per year in SSA (or 0.6 times the size of the current 
HRHA population in the region), 199 HRHA per year in NSSA (or 0.3 times the size of 
the current HRHA population), and 494 HRHA per year in SA (or 1.5 times the size of 
the current HRHA population). With feedback, as shown in Table 3, this rate is 2.5 times 
higher in SSA (that is, 1,931 HRHA per year or 1.4 times the size of the current HRHA 
population in the region), 2.7 times higher in NSSA (that is, 532 HRHA per year or 0.8 
times the size of the current HRHA population), and 2.2 times higher in SA (that is, 1085 
HRHA per year or 2.2 times the size of the current HRHA population). The feedback 
effect also significantly affects the sustainability of universal ART coverage beyond year 
10. For instance, without feedback, universal coverage with 1,287 HRHA per year is 
sustainable beyond year 10 for SSA (119% coverage in steady state). Similarly, 
universal coverage is easily sustainable with rates of 199 HRHA per year for NSSA 
(190% coverage in steady state) and 494 HRHA per year for SA in steady state (99% 
coverage in steady state). With feedback however, as shown in Figure 2, universal ART 
coverage beyond year 10 is not sustainable for SSA with an inflow of 1,931 HRHA per 
year. Indeed, steady-state universal coverage would require an inflow of 3,028 HRHA 
per year for SSA (469 for NSSA and 2,294 for SA). 
 
8 < Figure 2 > 
 
Result 2: HRHA ART coverage does not appreciably affect total population ART 
coverage in steady state. The reasons for this vary for the different regions (Table 2 and 
Figure 3).  
 
< Figure 3 > 
 
In NSSA, the total HRHA population (675) is small enough and the incidence of HIV 
among HRHA is low enough (0.024% per year) that almost no infected HRHA enter the 
pool of HIV-positive HRHA needing treatment every year. Therefore the need for ART 
among HRHA is essentially zero. In SA, the incidence of HIV among HRHA is higher 
(2.4% per year) but HRHA emigration is so high (28% per year, compared with 9% per 
year for SSA and 2% per year for NSSA) that only a negligible number of HRHA enter 
the pool of HIV-positive HRHA needing treatment every year. In SSA, HRH HIV 
incidence is considerable (0.421% per year), but the number of HRHA needing 
treatment in steady state is small (4 out of a total of 1,334), so that population ART 
coverage in SSA is insensitive to changes in HRHA ART coverage.  
 
Result 3: HRHA inflow and emigration have the most significant effects on population 
ART coverage (Table 2 and Figure 3).  
 
A 25% increase in HRHA inflow increases ART coverage among the overall population 
by 9-21% (16% in SSA; 9% in NSSA; 21% in SA). A 25% decrease in HRHA emigration 
increases ART coverage by 11% in SSA, by 22% in SA, and by 3% in NSSA. Setting 
emigration to zero has a drastic effect on population ART coverage, increasing 
coverage in year 10 by 54% in SSA, by 157% in SA, and by 14% in NSSA. 
  
Result 4: Sustainable universal population ART coverage in SSA and SA can be 
achieved beyond year 10 with much lower increases in HRHA inflow if HRHA 
9 emigration is reduced. The alternative to reducing emigration is a several-fold increase 
in HRHA inflow (Table 3 and Figure 2). 
 
In order to achieve universal population ART coverage in SSA in year 10, we can 
increase the HRHA inflow to 1,931 HRHA per year. However, at this level of HRHA 
inflow and the base-case emigration level, universal ART coverage is not sustainable 
and drops to 89% in steady state (Figure 2). If, by contrast, HRHA emigration is set to 
zero, we need a substantially smaller HRHA inflow rate (1,262 HRHA per year) to both 
achieve universal ART coverage in year 10 and sustain it in steady state. In SA, 
universal coverage is obtained in year 10 with an HRHA inflow rate of 1,085 per year, 
but – because of high base-case HRHA emigration (28% per year) – ART coverage falls 
to 80% in steady state. In contrast, if emigration from SA is reduced to 0, universal 
coverage can be maintained by an inflow rate of 399 per year. In NSSA, the HRHA 
inflow rate required to achieve universal coverage by year 10 (532 HRHA per year) will 
be sufficient to sustain universal coverage in steady state without decreasing the level 
of HRHA emigration below its base-case value (because at 2% per year base-case 





Although the findings in the Results section are compelling, the results are numerical, 
that is, they reflect particular choices of model parameters (from Table 1). Similarly, the 
sensitivity analysis in the previous section is for limited variation of a few key 
parameters. Deeper insight into the model’s behavior and wider sensitivity analysis are 
possible by analyzing the model’s steady-state behavior. To do that, we first present the 




t   = time period,    0, , . t =∞ K
10 L   = latency period from start of infection to needing treatment (for both HRHA and 
patients in the general population). 
φ   = number of HIV/AIDS patients treatable by one HRHA. 
H
t H  = number of healthy HRHA at the beginning of period  .  t
k I
t H   = number of HIV-infected HRHA who do not yet need antiretroviral treatment 
(ART) at the beginning of period t , who were infected   periods ago, 
. 
k
0, , 1 kL =− K
N
t H  = number of HRHA needing ART at the beginning of period t . 
T
t H   = number of HRHA needing and receiving ART at the beginning of period  .  t
U
t H   = number of HRHA needing but not receiving ART at the beginning of period t . 
t H   = total number of HRHA at the beginning of period  .  t
T
t P   = population receiving ART at the beginning of period t . 
U
t P   = population needing but not receiving ART at the beginning of period t . 
t P  = total population needing ART at the beginning of period t . 
 
The term 'rate', below, always means a fraction of the existing population and is always 
per period. It stands for the annual probability of an individual in the population 
experiencing an event (for instance, the annual probability of death, HIV infection, or 
emigration). Events are assumed to be independent over time. 
 
,,,
H ITU mm mm = mortality rates for healthy, infected, treated, and untreated HRHA.  
,,,
H ITU ee ee = emigration rates for healthy, infected, treated, and untreated HRHA. 
,
TP UP mm = mortality rates for people needing and receiving ART, and for people needing 
but not receiving ART. 
G m   = mortality rate for the general population. 
H i   = HRHA HIV incidence rate. 
H a   = Number of new HRHA per period. 
11 P a   = Number of people newly infected with HIV per period. 
H
t c   = HRHA ART coverage in period t . 
c   = population ART coverage in period t . 
 
We assume regularity conditions on the parameters of the form  
1
HH me +≤ ,  ,  ,  1
II me +≤ 1
TT me +≤ 1





The following formulation assumes that all quantities are continuous. Initial values at 
 for all quantities indexed by t  are given. Then for  0 t = 1,2, , t = ∞ K , the HRHA 
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If HRHA coverage is exogenous and time independent, 
H
t c is some constant  . 
Therefore the foregoing equations completely describe the evolution of HRHA over 
time. If HRHA ART coverage is endogenous but the same as population ART coverage, 
H c
12 then the evolution of HRHA is completely specified by using  min( ,1.0)
H
tt t cH P φ = , 
where   is obtained from the following population evolution equations for  :  t P 1,2, , t =∞ K
 
11 (1 ) (1 ) (1 ) ,
min( , ),
min( , ).



















HRHA needed for universal population ART coverage in the steady state: At universal 
coverage  HP φ ∞ = ∞  (where ∞ denotes steady state). In steady state, patient inflow 
must equal patient outflow, that is,  (1 )
P GL T P am P m ∞ −= , which gives the following 














The expression above allows us to compare HRHA requirements for universal 
population ART coverage in a model with feedback (caused by a lower mortality rate 
among those receiving versus those not receiving ART) with a model without feedback. 
Given the mortality rates from Table 1,  , and  , the model without 
feedback would use   in the above expression in place of  . The model 
with feedback therefore requires 4.6 times more HRHA for universal coverage in steady 
state than the model without feedback. 
0.05






13 HRHA requirement as a function of a pre-specified steady-state population ART 
coverage  : In steady state, we must have  0 c ≤≤ 1 (1 ) (1 ) ()
P GL T P U P am P c m c m ∞ −= + − . 















Figure 4 shows how the annual inflow of HRHA required to reach steady state for a 
model with feedback increases nonlinearly with desired population coverage, compared 
with a linear increase for a model without feedback. The magnitude of the difference 
indicates the impact of feedback. The required number of HRHA for the model with 
feedback is 1.6 times that for a model without feedback at 50 percent coverage, 2.4 
times at 75 percent coverage, 3.4 times at 90 percent coverage, and 4.6 times at 100 
percent coverage. 
 
< Figure 4 > 
 
Computing steady-state population ART coverage for given model parameters: To 
compute the steady-state coverage for a given a set of model parameters, we can 
obtain the steady-state versions of HRHA subpopulations in the exogenous HRHA 
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14 For exogenous HRHA coverage,  ,( 1 )
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The foregoing formulae readily allow the steady-state HRHA pool size to be computed. 
Its sensitivity to changes in various parameters – such as HRHA coverage, emigration, 
and HIV incidence rates – can then be plotted over their full range. Figures 5-7 show 
plots of steady-state HRHA pools size for SSA by HRHA ART coverage, HRHA 
emigration rate, and HRHA ART coverage, respectively. Figure 8 shows the plot of 
HRHA pool size for SSA when all three parameters (HRH ART coverage, HRHA 
emigration rate and HRHA ART) coverage are simultaneously increased from 0% to 
100%. 
 
< Figures 5-8 > 
 
Figure 5 shows that HRHA emigration rate for SSA has the most pronounced effect on 
decreasing the steady-state HRHA pool size in the 0-40% emigration range. If fewer 
HRHA are available, fewer emigrate. Therefore at lower HRHA pool sizes the effects of 
emigration in reducing the HRHA pool size become smaller. However, emigration rates 
affect healthy and infected HRHA equally, so the proportion of healthy to infected HRHA 
remains unaltered by emigration rates. 
 
Figure 6 shows that the steady-state HRHA pool size for SSA is relatively insensitive to 
changes in the HRHA HIV incidence rate, but that the number of infected HRHA is quite 
sensitive to such changes. This peculiarity is due to the high emigration rate for SSA 
(0.09), a rate that is higher than the mortality rate of healthy HRHA (0.06). Most infected 
15 HRHA therefore emigrate or die within their 10-year latency period, at a level 
comparable to their combined emigration and mortality rate if they had not been 
infected. This makes the total HRHA pool size insensitive to the HRHA HIV incidence 
rate, even though at any given time high HRHA HIV incidence means more HRHA are 
infected as shown in Fig. 6.  
 
Figure 7 shows the above phenomenon from another view. Because few infected HRHA 
survive emigration or mortality through the 10-year latency period, HRHA ART coverage 
does not have an appreciable effect on the total HRHA pool size. The number of healthy 
HRHA is of course independent of the HRHA ART coverage and is shown in Fig. 7 only 
for comparison. 
 
In the exogenous HRHA coverage case, H ∞ evolves independently of the patient 
population. The steady-state patient population can then be computed from the 
expression  ( ) ,, (1 ) min( ) min( )
PG L T P am H P mP H P m φφ ∞∞ ∞ ∞∞ −= + −
U P . This gives 
 




























In summary, the steady-state HRHA pool size, and thus population ART coverage, is 
very sensitive to changes in the HRHA emigration rate and is insensitive to changes in 
HRHA HIV incidence and HRHA ART coverage (Figures 5-8). Figure 5 shows that the 
sensitivity of the steady-state HRH pool size to changes in HRHA emigration rates 
increases with decreasing emigration rates. Figures 6 and 7 show that the steady-state 
HRH pool size is insensitive to changes in HRHA HIV incidence and HRHA ART 




A number of policy implications flow from our model results. 
 
Policy implication 1: Strategies to achieve universal ART coverage in developing 
countries are bound to fail if they do not take into account that higher current HRHA 
numbers will lead to higher future HRHA need. 
 
One of the motivations for our study was to investigate the feedback effect from HRHA 
numbers on HRHA need. We find that even at low initial ART coverage, say 30%, 
ignoring feedback may result in substantial overestimation of the population ART 
coverage that can be achieved in the long run. Moreover, as ART coverage increases, 
the feedback effect becomes increasingly important. For instance, without feedback, an 
annual inflow of at least 788 HRHA would be required to achieve universal ART 
coverage in SSA 10 years from now, while with feedback that number would rise to 
1,931 HRHA (Table 3). If no feedback occurred, the number of HRHA needed to 
achieve universal ART coverage 10 years from now would be sufficient to maintain 
near-universal coverage beyond year 10, while with feedback universal coverage could 
not be sustained at the inflow rate needed to achieve universal coverage in year 10. As 
ART programs in developing countries continue to scale up treatment in the coming 
years, they will increasingly fall victim to their own success, constantly needing to 
increase the number of HRHA simply to maintain ART coverage levels. 
 
Our model assumes that the number of HRHA needed to treat 1,000 patients is 
constant over time. Changes in the mix of patients, the need for treatment, treatment 
technology, or experience may make an adjustment to the HRHA-to-patient ratio 
necessary. On the one hand, a plausible expectation is that more health workers will be 
needed to treat a fixed number of patients as ART programs mature. Patients in initial 
treatment cohorts may, on average, require less HRHA time because they are healthier, 
better educated, or have more effective social support than patients who access ART in 
later stages of ART roll-out. In addition, as the average time on ART increases, 
17 adherence failure (Mannheimer et al. 2006),  ART failure due to viral resistance, and 
adverse events associated with ART (Orrell et al. 2007) will become more common, 
thereby increasing the amount of time that HRHA need to spend per patient. On the 
other hand, technological advances, such as combination pills, better patient 
management systems, or increasing experience in providing ART among HRHA, could 
reduce the HRHA-to-patient ratio over time. Furthermore, as patients gain treatment 
experience, knowledge about how to take antiretroviral medicines and how to deal with 
the side effects of ART may spread through the population, replacing time-consuming 
interactions between patients and HRHA with interaction between patients. 
 
Policy implication 2: Even to maintain the current level of ART coverage in developing 
countries, health policies must be put into place to either increase the number of HRHA, 
reduce HIV incidence, or both. 
 
While the feedback effect from the current level of HRHA to future HRHA need is 
moderately large at current levels of population ART coverage, we find that current 
levels of coverage will not be maintained in SAA and SA under base-case assumptions 
because of the continued high inflow of people needing ART into the population. If 
inflows into the pool of HRHA and outflows caused by emigration or death remain at 
their current levels, in the next five years, ART coverage will decline in SSA from 28% to 
25% and in SA from 33% to 19%. The current level of ART coverage has been 
achieved as a result of immense efforts by national governments in developing 
countries and international initiatives, including WHO’s 3 by 5 Program; the Global Fund 
to Fight AIDS, Tuberculosis and Malaria; and PEPFAR (Bärnighausen 2007). Even if 
these efforts are further intensified, universal coverage is unlikely to be achieved without 
substantial success in reducing the continued high incidence of HIV in developing 
countries, especially in SSA. 
 
This conclusion from our model rests on the assumption that the estimate of the inflow 
of people into the pool of those needing treatment is valid and that HIV incidence in the 
three base-case regions has been approximately constant over the last 10 years. The 
18 rate of inflow of people needing ART is a function of HIV incidence and mortality during 
the latency period between HIV infection and treatment, two parameters that are 
uncertain. For instance, UNAIDS and WHO provide a range of 1.4 million to 2.4 million 
people around their estimate of 1.7 million people newly infected with HIV in SSA during 
2007 as the “boundaries within which the actual numbers lie, based on the best 
available information” (UNAIDS and WHO 2007). However, while the precise parameter 
values are uncertain, our conclusion that current levels of ART coverage will not be 
maintained under base-case assumptions is robust to substantial changes in the base-
case patient inflow rate.  
 
Our model does not take into account other effects of increased HRHA that may affect 
future need for HRHA, such as reductions in the probability of HIV transmission per 
risky sex act (because ART reduces viral load) (Quinn, et al. 2000)
 and changes in risk 
behavior because of the availability of ART (Kennedy, O'Reilly, Medley, and Sweat 
2007). Future models need to investigate whether such effects could alter the main 
results of our study. 
 
Policy implication 3: To achieve universal ART coverage, the inflow of HRHA into ART 
programs in developing countries will need to increase substantially. In SSA and SA, 
policies that increase this inflow will be much more effective if accompanied by 
interventions to decrease HRHA emigration rates.  
 
Even at current coverage levels of around 30%, ART programs in many developing 
countries struggle to find sufficient HRHA to further scale up ART (Médecins Sans  
Frontières 2007b; Ooms et al. 2007). We find that under a wide range of assumptions, 
the workforce required to treat HIV/AIDS patients will need to be increased dramatically 
if universal ART coverage is to be achieved. Such an increase may be especially 
difficult to achieve in SSA. 
 
The capacity for providing health care education is currently very limited in SSA (WHO 
2006). For instance, Eckhert (2002) estimates that 5,100 students graduate each year 
19 from medical school in SSA. A simple comparison to an estimate of the number of 
doctors that are currently lacking in SSA to ensure the delivery of “essential health 
interventions” helps to put this number into perspective (Joint Learning Initiative on 
Human Resources for Health (JLI) 2004, p. 23). JLI estimates that “a density of 2.5 
workers per 1,000 may be considered a threshold of worker density necessary to attain 
adequate coverage of some essential health interventions and core MDG-related 
[Millennium Development Goal-related] health services” (JLI 2004, p.23) and derives 
from this density threshold that “sub-Saharan countries would immediately require an 
additional 1 million doctors, nurses, and midwives” (JLI 2004, p. 72). Using recent data 
on absolute numbers of doctors, nurses, and midwives available in the period 2002-
2004 from the WHO Global Atlas on the Health Workforce (WHO 2007), we calculate an 
average ratio of 6 nurses and midwives to 1 doctor in SSA.
1 According to this ratio 
143,000 of the 1 million health workers estimated to be needed in SSA are doctors. 
Assuming that none of the existing doctors and none of the doctors newly added to the 
workforce emigrated or died, at existing education capacity it would take 28 years to 
add 143,000 doctors to the current health workforce in SSA. 
 
We estimate that 1,931 HRHA would need to be added annually to the HRHA workforce 
in SSA in order to achieve universal ART coverage. According to the health worker-to-
patient ratios measured by Hirschhorn and colleagues (2006), the 1,931 HRHA 
represent 1,931 to 3,862 doctors (see Methods, p. 4). The annual need for additional 
doctors to achieve universal ART coverage in SSA estimated at the upper bound could 
not be met given the current education capacity in the region, even if all graduating 
doctors started working in ART programs. While the annual need for additional doctors 
estimated at the lower bound could theoretically be met, allocating 1,931 (or 38%) of the 
5,100 doctors who are estimated to graduate from medical school in SSA each year to 
ART programs would very likely worsen the already severe shortage of doctors 
delivering non-ART health services. 
 
                                                            
1 Data was available for 45 of the 48 countries in SSA.  We compare the total number of doctors in all 45 
countries to the total number of nurses and midwives. 
20 Another option to increase the number of HRHA in developing countries is to attract 
international graduates to work in ART programs. SA, for instance, is actively recruiting 
international doctors and nurses to work in rural health centers (Rural Health Initiative 
2007). However, the pool of physicians from developed countries who are willing to 
work in developing-country ART programs is probably quite limited, and international 
health workers may perform less well than locally educated workers, for example, 
because of language difficulties or lack of familiarity with the local health care system. 
 
It seems unlikely that countries in SSA will be able to meet the HRHA need to achieve 
universal coverage, unless health care education capacity is increased. An increase in 
the capacity to train health workers, however, may itself be constrained by human 
resources shortages (Bossert et al. 2007). In many developing countries, not only are 
health care teachers scarce (WHO 2006), but so are secondary school graduates 
sufficiently qualified to undertake an education in health care (Kingsley and Juliet 2001).
 
 
We find that the increases in HRHA inflow required to achieve universal ART coverage 
are substantially reduced if HRHA emigration rates are decreased. A number of policy 
options exist to stem the current high levels of emigration from SSA to developed 
countries. These options include awarding “conditional scholarships” for health care 
education, whereby qualified candidates receive scholarships if they enter into a 
contract to work on delivering ART in the country where they were educated for a 
specific number of years following their graduation (Bärnighausen and Bloom 2007; 
Bärnighausen and Bloom 2008); training health workers to deliver ART who are not 
internationally mobile, because their health care profession is not recognized in 
developed countries (such as health officers), but who can (partially) replace 
internationally mobile workers (such as doctors and nurses) (Dovlo 2004); and requiring 
developed countries to adopt so-called ethical recruiting practices, which limit the 
admission of health workers from developing countries (Stilwell et al. 2003).  
 
Various options are available to increase the inflow of HRHA. First, health workers who 
currently work in the general health care system can leave their positions and become 
21 part of the workforce treating HIV/AIDS patients. In countries with generalized HIV 
epidemics, large proportions of inpatient and outpatient admissions are related to HIV 
(Bardgett, Dixon, and Beeching 2006; Dedicoat, Grimwade, Newton, and Gilks 2003; 
Floyd, Reid, Wilkinson, and Gilks 1999). Since ART decreases health care utilization 
among HIV-positive people (Harling, Orrell, and Wood 2007), expansion of ART 
coverage may free up health care capacity to treat other patients. Thus in the short run, 
health systems in some developing countries may be able to sustain a shift of health 
workers into ART programs without detrimental effects on access to care that is not 
related to HIV/AIDS. However, these health systems are unlikely to be able to sustain 
large flows of health workers into ART programs over many years without an adverse 
impact on performance, especially if the integration of ART programs into the overall 
system is not well managed (Schneider, Blaauw, Gilson, Chabikuli, and Goudge 2006).  
 
One of our aims was to examine the extent to which a reduction of HIV incidence 
among HRHA and an increase in HRHA ART coverage are effective interventions to 
increase the number of HRHA in the long run. Health policy makers and researchers 
have called for an increased focus on HIV prevention and AIDS treatment among the 
health workforce (Shisana 2007). We find that neither HIV prevention among health 
workers nor HRHA ART coverage are important determinants of long-term population 
ART coverage. However, these findings are certainly not arguments against ensuring 
that health workers have access to HIV prevention services and ART, which can be 
supported on a number of grounds (Macklin 2004). In addition, if – as Dovlo (2007) 
asserts – the provision of effective HIV prevention and free ART in the workplace 
reduce health worker emigration, our results provide an indirect argument for such 









If efforts to achieve universal ART coverage in the developing world are to succeed, 
large numbers of health workers must enter the workforce to provide ART on an 
ongoing basis. Projections of the numbers of health workers required must take into 
account positive feedback phenomena. At high coverage levels, the effectiveness of 
ART in reducing mortality among HIV-positive people becomes the main determinant of 
HRHA need. HIV prevention that is effective in reducing HIV incidence and interventions 
to decrease health worker emigration from developing to developed countries could be 
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Parameters SSA  NSSA  SA  Sources 
HRHA work lifetime (years)  17  30  18  World Bank 2007 
HRHA emigration rate (%)  0.09  0.02  0.28  Docquier and Bhargava 2007b 
Initial HRHA HIV prevalence (%) 5.00  0.30  18.80  UNAIDS/WHO  2007 
HRHA HIV incidence rate (%)  0.421  0.024  2.400  UNAIDS/WHO 2006, Rehle et al. 2007 
Initial total number of HRHA  1,340  675  325  Hirschhorn et al. 2006 
Number of people newly infected with HIV (per year)  1,700,000  734,000  571,000  UNAIDS/WHO 2007  
Initial size of total population needing ART  4,800,000 2,297,000  1,000,000  WHO/UNAIDS/UNICEF 2007 
Initial size of population needing but not receiving ART 3,460,000  1,622,000  675,196 WHO/UNAIDS/UNICEF  2007 
Initial size of population receiving ART  1,340,000 675,000 324,804  WHO/UNAIDS/UNICEF 2007 
 
HRHA = human resources to treat HIV/AIDS, ART = antiretroviral treatment, SSA = sub-Saharan Africa, NSSA = non-sub Saharan African low- and 
middle-income countries, SA = South Africa. HRHA emigration rate is the annual probability of death in HRHA.  HRHA HIV incidence is the annual 







































of    
HRHA
Base Case 0 28% 4,800,000 1,340 29% 2,297,000 675 33% 1,000,000 325
10 25% 5,419,672 1,332 28% 2,427,224 673 19% 1,683,736 321
SS 24% 5,468,341 1,334 28% 2,437,104 673 18% 1,737,513 321
HRHA emigration rate +25% 10 22% 5,328,464 1,184 27% 2,412,525 647 16% 1,645,635 266
SS 22% 5,334,304 1,160 26% 2,393,230 616 16% 1,693,854 266
HRHA emigration rate -25% 10 27% 5,524,439 1,506 29% 2,442,686 700 23% 1,736,318 402
SS 28% 5,653,099 1,569 30% 2,490,373 741 23% 1,804,061 406
HRHA ART coverage +25% 10 25% 5,419,899 1,332 28% 2,427,224 673 19% 1,683,278 320
SS 24% 5,466,596 1,333 28% 2,437,104 673 18% 1,737,512 321
HRHA ART coverage -25% 10 25% 5,419,684 1,332 28% 2,427,224 673 19% 1,683,539 320
SS 24% 5,468,339 1,334 28% 2,437,104 673 18% 1,737,513 321
Number of new HRHA per year +25% 10 29% 5,579,706 1,595 30% 2,467,646 744 23% 1,736,732 400
SS 29% 5,726,107 1,662 33% 2,568,433 841 22% 1,800,754 402
Number of new HRHA per year -25% 10 20% 5,255,958 1,063 25% 2,387,178 602 15% 1,630,157 241
SS 19% 5,208,036 999 22% 2,306,445 505 14% 1,674,351 241
HRHA HIV incidence rate +25% 10 25% 5,419,536 1,332 28% 2,427,881 674 19% 1,683,530 321
SS 24% 5,467,778 1,333 28% 2,437,152 673 18% 1,737,513 321
HRHA HIV incidence rate -25% 10 25% 5,419,534 1,332 28% 2,427,195 673 19% 1,683,496 321
SS 24% 5,470,193 1,335 28% 2,437,102 673 18% 1,737,513 321
HRHA emigration rate 0% 10 38% 5,943,874 2,254 32% 2,492,097 789 49% 2,078,777 1,017
SS 47% 7,009,592 3,303 39% 2,750,795 1,074 61% 2,838,608 1,728
HRHA ART coverage 100% 10 25% 5,423,522 1,338 28% 2,427,844 674 19% 1,683,966 321
SS 24% 5,471,669 1,337 28% 2,438,069 674 18% 1,737,515 321
HRHA emigration rate 0% and 10 38% 5,952,332 2,270 32% 2,492,754 790 49% 2,085,511 1,030
HRHA ART coverage 100% SS 48% 7,087,019 3,402 39% 2,753,451 1,077 65% 3,034,062 1,978  
 
 
HRHA = human resources to treat HIV/AIDS, ART = antiretroviral treatment, SSA sub-Saharan Africa; NSSA non-sub Saharan African low- and 
middle-income countries, SA = South Africa, SS = steady state. HRHA emigration rate is the annual probability of death in HRHA.  HRHA HIV 
incidence is the annual probability of HIV infection in HIV-negative HRHA. 
32 Table 3: Annual number of new HRHA needed to achieve universal ART coverage by year 10 
 
HRHA per year
Scenario SSA NSSA SA 
Base case 1,931 532 1,085
HRHA emigration rate 0%  1,262 470 399
HRHA ART coverage 100%  1,931 532 1,085




HRHA = human resources to treat HIVAIDS, ART = antiretroviral treatment, SSA = sub-Saharan Africa, NSSA = non-sub Saharan African low- 
and middle-income countries, SA = South Africa.  
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35 Figure 3: Sensitivity of population ART coverage to model parameters 
 
















HRHA = human resources to treat HIVAIDS, ART = antiretroviral treatment, SSA = sub-Saharan Africa, NSSA = non-sub Saharan African low- 
and middle-income countries, SA = South Africa  
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HRHA = human resources to treat HIVAIDS, ART = antiretroviral treatment, SSA = sub-Saharan Africa  
 
 
40 Figure 8: Steady-state population ART coverage for SSA as a function of HRHA emigration rate, HRHA HIV 
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HRHA = human resources to treat HIVAIDS, ART = antiretroviral treatment, SSA = sub-Saharan Africa  
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